Skip Navigation

Medicare market shares of mail-order diabetes test strips from October through December 2016

Series Title(s):
Data brief (United States Department of Health and Human Services, Office of Inspector General)
Contributor(s):
United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body.
Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Language(s):
English
Format:
Text
Subject(s):
Competitive Bidding
Insurance, Health, Reimbursement
Medicare -- economics
Reagent Strips -- economics
Humans
United States
United States. Department of Health and Human Services.
Genre(s):
Technical Report
Abstract:
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) required the Centers for Medicare & Medicaid Services (CMS) to phase in a Competitive Bidding Program for durable medical equipment, prosthetics, orthotics, and supplies. In July 2013, the program was expanded to include a National Mail-Order Program for diabetes testing supplies. The Medicare Improvements for Patients and Providers Act (MIPPA) prohibits CMS from awarding a contract to a supplier of diabetes test strips if the supplier's bid does not cover at least 50 percent, by volume, of all types of diabetes test strips on the market. (This is known as the "MIPPA 50-percent rule.") MIPPA requires the Office of Inspector General (OIG) to determine the market shares of the types of diabetes test strips before each round of competitive bidding. On July 1, 2016, CMS began accepting claims for the current round of the National Mail-Order Program, which ends on December 31, 2018. This is the third of three OIG reports on the Medicare market shares of diabetes test strips in 2016. CMS will use the results from the second OIG report (OEI-04-16-00471, February 2017) to determine bidders' adherence with the MIPPA 50-percent rule for the next round of competitive bidding. The first and third reports provide CMS with additional information on the market shares of diabetes test strips provided by the National Mail-Order Program. OIG will complete future evaluations as mandated by MIPPA or, if appropriate, as requested by CMS.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
1 online resource (1 PDF file (14 pages))
Illustrations:
Illustrations
NLM Unique ID:
101737776 (See catalog record)
Series Title(s):
Data brief (United States Department of Health and Human Services, Office of Inspector General)
Contributor(s):
United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body.
Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Language(s):
English
Format:
Text
Subject(s):
Competitive Bidding
Insurance, Health, Reimbursement
Medicare -- economics
Reagent Strips -- economics
Humans
United States
United States. Department of Health and Human Services.
Genre(s):
Technical Report
Abstract:
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) required the Centers for Medicare & Medicaid Services (CMS) to phase in a Competitive Bidding Program for durable medical equipment, prosthetics, orthotics, and supplies. In July 2013, the program was expanded to include a National Mail-Order Program for diabetes testing supplies. The Medicare Improvements for Patients and Providers Act (MIPPA) prohibits CMS from awarding a contract to a supplier of diabetes test strips if the supplier's bid does not cover at least 50 percent, by volume, of all types of diabetes test strips on the market. (This is known as the "MIPPA 50-percent rule.") MIPPA requires the Office of Inspector General (OIG) to determine the market shares of the types of diabetes test strips before each round of competitive bidding. On July 1, 2016, CMS began accepting claims for the current round of the National Mail-Order Program, which ends on December 31, 2018. This is the third of three OIG reports on the Medicare market shares of diabetes test strips in 2016. CMS will use the results from the second OIG report (OEI-04-16-00471, February 2017) to determine bidders' adherence with the MIPPA 50-percent rule for the next round of competitive bidding. The first and third reports provide CMS with additional information on the market shares of diabetes test strips provided by the National Mail-Order Program. OIG will complete future evaluations as mandated by MIPPA or, if appropriate, as requested by CMS.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
1 online resource (1 PDF file (14 pages))
Illustrations:
Illustrations
NLM Unique ID:
101737776 (See catalog record)